Dr. McCracken is a board-certified, fellowship trained Neurosurgical Oncologist who specializes in the surgical treatment of primary and metastatic tumors affecting the brain, pituitary gland and skull-base. He is well-versed in many different surgical approaches including open and minimally invasive craniotomies, endoscopic approaches to the skull base and pituitary gland, and stereotactic radiosurgery with both Gamma Knife and Linear Accelerator based technology. He leads the Piedmont Neurosurgical Oncology Service, is Co-Director of the Piedmont Brain Tumor Center. His team prides itself on an integrated, multi-disciplinary care of patients with a close working relationship with Neuro-Oncology, Radiation Oncology, Neuro-Pathology, Neurology, and Physical and Occupational Therapy. He is an advocate for promoting research through translational clinical trials and adapting innovative surgical technologies to help bring the best care to patients from all over the Southeast. Dr. McCracken currently serves on a multitude of investigational clinical trials for glioblastoma, metastatic brain disease, and meningioma. He is an advocate for the use of innovative surgical therapies such as Gamma Tile brachytherapy and the imaging agent Gleolan (5-ALA) in the resection of glioblastoma. Dr. McCracken also treats facial pain known as Trigeminal Neuralgia. Through a combination of medications, surgical microvascular decompression, stereotactic radiosurgery, or percutaneous ablative type procedures he can provide a solution to almost all patient experiencing this disease. He is a strong supporter of the Southeastern Brain Tumor Foundation and the American Brain Tumor Association. He is a member of the Congress of Neurological Surgeons, The American Association of Neurological Surgeons, the Georgia Neurosurgical Society, and The North American Skull Base Society.